Jul 21, 2019
Personalized gene-edited immune cell therapy for patients with solid cancers: New data establishes approach for verifying patient-specific cancer mutation targets
Jul 10, 2019
Geneos Therapeutics Announces First Patient Dosed with its DNA-based, Neoantigen-Targeting Personalized Vaccine Technology
Jun 26, 2019
Elios Therapeutics Announces Appointment of Phillip Johnson as Chief Financial Officer
Jun 25, 2019
Pepscan Produces Clinical Peptides for Innovative Personalized Cancer Vaccine Trial
Jun 19, 2019
Nouscom Demonstrates Preclinical Proof of Concept for Personalized Cancer Neoantigen Vaccine in Combination With Immune Checkpoint Blockade to Eradicate Large Tumors
Jun 03, 2019
Nouscom - IND for NOUS-209, an 'off-the-shelf' Neoantigen Cancer Vaccine, Cleared by FDA to Commence Clinical Development in MSI Solid Tumors
May 07, 2019
BioLineRx Announces FDA Approval of IND Application for AGI-134, a Novel Immunotherapy Anti-Cancer Vaccine for Solid Tumors
Apr 08, 2019
Mount Sinai Researchers Develop Treatment That Turns Tumors Into Cancer Vaccine Factories
Apr 02, 2019
Leaps by Bayer and Khloris join forces to develop induced pluripotent stem cells (iPSCs) as breakthrough anti-cancer vaccines
Mar 27, 2019
Enterome to Present Data on Its Innovative Microbiome-derived Molecular Mimicry Approach to Cancer Immunotherapy at AACR 2019
Mar 25, 2019
EpiVax Oncology To Present Latest Research On The Importance Of Identifying And Removing, Using Machine-Learning Based Advanced Computational Tools, Inhibitory Neoantigens From Therapeutic Cancer Vaccines, At AACR Annual Meeting 2019
Mar 12, 2019
FDA In Brief: FDA takes new steps to broaden patient participation in cancer clinical trials, advancing policies to promote inclusion of pediatric patients and patients with medical conditions that can occur alongside cancer
Mar 01, 2019
AIVITA Biomedical to Present Cancer Vaccine Data at 2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Jan 29, 2019
Genetic Immunity Expands JSC Pharmadis Partnership by Granting 20 Cancer Vaccine Licenses for Russia and Commonwealth of Independent States
Jan 25, 2019
Torque Appoints John Cox as Executive Chairman to Board of Directors and Lisa Butterfield, PhD, to Scientific Advisory Board
Jan 24, 2019
Inovio Reports 2nd Patient Achieving Full Remission from HPV-Related Head & Neck Cancer after Treatment with Synthetic DNA Vaccine and a PD-1 Checkpoint Inhibitor
Nov 13, 2018
DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer
Nov 08, 2018
CytRx Corporation Highlights NantCell Inc's Clinical Data with Aldoxorubicin Presented at the Society for Immunotherapy of Cancer's 33rd Annual Meeting
Nov 07, 2018
California research team publishes promising results from peptide based universal cancer vaccine
Oct 15, 2018
Targovax Reports Encouraging Disease-free Survival (DFS) Data From Tg01 Trial in Resected Pancreatic Cancer